Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
NKGen Biotech Inc. (OTC : NKGN) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
NKGen Biotech is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell therapies to treat neurodegenerative and oncological diseases utilizing our proprietary SNK (super-activated) platform. Spearheading our industry disrupting technology are our Senior Leadership, Senior Advisors and Management Team. Together they bring a wealth of knowledge and expertise in neurodegeneration and immune-oncology and are passionate and excited about the work we are doing to strengthen the immune system.
Quote
| Last: | $0.06 |
|---|---|
| Change Percent: | 0.0% |
| Open: | $0.06 |
| Close: | $0.06 |
| High: | $0.06 |
| Low: | $0.06 |
| Volume: | 495 |
| Last Trade Date Time: | 06/03/2026 11:48:02 am |
Stock Data
| Market Cap: | $7,836,134 |
|---|---|
| Float: | 57,660,885 |
| Insiders Ownership: | N/A |
| Institutions: | 1 |
| Short Percent: | 1419392% |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.nkgenbiotech.com |
| Country: | US |
| City: | Santa Ana |
Recent News Releases
Subscribe to Our Newsletter
**MWN-AI FAQ is based on asking OpenAI questions about NKGen Biotech Inc. (OTC: NKGN).
